The main pathophysiologic mechanisms of Trousseau's syndrome are malignancy-related hypercoagulability and tumor cell injury of the vascular endothelium, followed by platelet aggregation and activation and consumption of anti-thrombin III and thrombomodulin. This evidence concerns the gene THBD and neoplasm.